OmniAb (OABI) FCF Margin (2022 - 2026)

OmniAb's (OABI) quarterly FCF Margin came in at 35.22% in Q1 2026, up 35190.0% year-on-year from N/an in Q1 2025, and up 56.3% on a QoQ basis from 80.6% in Q4 2025.

OmniAb (OABI) FCF Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of FCF Margin data on file, last reported at 35.22% in Q1 2026.

  • On a quarterly basis, FCF Margin rose 35190.0% year-over-year to 35.22% in Q1 2026; TTM through Mar 2026 was 89.91%, a 6012.0% increase from a year earlier, with the FY2025 full-year figure at 198.33%, down 4093.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 35.22%, up from 80.6% in the prior quarter.
  • Over the last five years, FCF Margin for OABI reached as high as 164.28% in Q1 2023 and fell as low as 460.3% in Q1 2024.
  • Historically, FCF Margin has averaged 124.46% across 5 years, with a median of 103.95% in 2024.
  • Across the five-year window, FCF Margin tumbled 62458 bps in 2024 and soared 35190 bps in 2026, its largest moves.
  • Year by year, FCF Margin stood at 27.4% in 2022, then sank by 631 bps to 200.21% in 2023, then soared by 71 bps to 58.41% in 2024, then tumbled by 38 bps to 80.6% in 2025, then soared by 56 bps to 35.22% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 35.22% in Q1 2026, 80.6% in Q4 2025, and 396.47% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -35.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.22%
Dec 31, 2025 -80.60%
Sep 30, 2025 -396.47%
Jun 30, 2025 -136.28%
Mar 31, 2025 -387.12%
Dec 31, 2024 -58.41%
Sep 30, 2024 -103.95%
Jun 30, 2024 -175.93%
Mar 31, 2024 -460.30%
Dec 31, 2023 -200.21%
Sep 30, 2023 -111.76%
Jun 30, 2023 -148.85%
Mar 31, 2023 164.28%
Dec 31, 2022 -27.40%
Sep 30, 2022 16.27%
Jun 30, 2022 -68.65%
Mar 31, 2022 94.87%